Ruxandra Draghia-Akli insider trades
Open-market stock purchases and sales by Ruxandra Draghia-Akli, EVP, Research & Development at Novavax Inc, from SEC Form 4 filings since Nov 11, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 3, 2026 | NVAX Novavax Inc | Bought (not open market) | — |
| Mar 3, 2026 | NVAX Novavax Inc | Sold (not open market) | $107K |
| Mar 3, 2026 | NVAX Novavax Inc | Sold (not open market) | — |
| Mar 2, 2026 | NVAX Novavax Inc | Bought (not open market) | — |
| Mar 2, 2026 | NVAX Novavax Inc | Bought (not open market) | $1.3M |
| Mar 2, 2026 | NVAX Novavax Inc | Bought (not open market) | — |
| Nov 11, 2025 | NVAX Novavax Inc | Bought (not open market) | — |
| Nov 11, 2025 | NVAX Novavax Inc | Sold (not open market) | $44.8K |
| Nov 11, 2025 | NVAX Novavax Inc | Sold (not open market) | — |
Companies traded
- NVAX Novavax Inc: other filings, last Mar 3, 2026
Get free alerts when Ruxandra Draghia-Akli files a new trade →